# Evaluation of Combination Nivolumab and Ipilimumab Immunotherapy in Patients With Advanced Biliary Tract Cancers

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/evaluation-of-combination-nivolumab-and-ipilimumab-immunotherapy-in-patients/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Oliver Klein,Damien Kee,Adnan Nagrial,Ben Markman,Craig Underhill,Michael Michael,Louise Jackett,Caroline Lum,Andreas Behren,Jodie Palmer,Niall C. Tebbutt,Matteo S. Carlino,Jonathan Cebon |
| Citations | 233 |
| DOI | 10.1001/jamaoncol.2020.2814 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://jamanetwork.com/journals/jamaoncology/articlepdf/2768631/jamaoncology_klein_2020_oi_200037_1599155071.5373.pdf |
| OpenAlex ID | https://openalex.org/W3046384500 |
| PMID | 32729929 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Michael Michael](https://scholariq.org/researchers/michael-michael/)

## Paper journal

- [JAMA Oncology](https://scholariq.org/journals/jama-oncology/)

## Paper primary topic

- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)

## Paper topics

- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Liver Diseases and Immunity](https://scholariq.org/topics/liver-diseases-and-immunity/)
- [Gallbladder and Bile Duct Disorders](https://scholariq.org/topics/gallbladder-and-bile-duct-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.